Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children-Reference-Cited by-同舟云学术

Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children

Published:2022-06-01 Issue:6 Volume:176 Page:576
ISSN:2168-6203
Container-title:JAMA Pediatrics
language:en
Short-container-title:JAMA Pediatr

Author:

Villacis-Nunez D. Sofia¹²,Jones Kaitlin²,Jabbar Aysha²,Fan Lucie³,Moore Whitney²,Peter Andrew S.²³⁴,Henderson Michaela²³⁴,Xiang Yijin³⁵,Kelleman Michael S.³⁵,Sherry Whitney²⁶,Chandrakasan Shanmuganathan²⁷,Oster Matthew E.²³⁴,Jaggi Preeti²⁸,Prahalad Sampath¹²⁹

Affiliation:

1. Division of Pediatric Rheumatology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia

2. Children’s Healthcare of Atlanta, Atlanta, Georgia

3. Emory University School of Medicine, Atlanta, Georgia

4. Sibley Heart Center, Atlanta, Georgia

5. Pediatrics Biostatistics Core, Atlanta, Georgia

6. Division of Hospital Medicine, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia

7. Division of Hematology, Oncology and BMT, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia

8. Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia

9. Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia

Publisher

American Medical Association (AMA)

Subject

Pediatrics, Perinatology and Child Health

Link

https://jamanetwork.com/journals/jamapediatrics/articlepdf/2790362/jamapediatrics_villacisnunez_2022_oi_220009_1653493585.80694.pdf

Reference22 articles.

1. Multisystem inflammatory syndrome in U.S. children and adolescents.;Feldstein;N Engl J Med,2020

2. Management of multisystem inflammatory syndrome in children associated with COVID-19: a survey from the International Kawasaki Disease Registry.;Elias;CJC Open,2020

3. COVID-19 and multisystem inflammatory syndrome in children and adolescents.;Jiang;Lancet Infect Dis,2020

4. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2.;Henderson;Arthritis Rheumatol,2021

5. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19.;Feldstein;JAMA,2021

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MIS-C Treatment: Is glucocorticoid monotherapy enough for mild cases?;The American Journal of Emergency Medicine;2024-09

2. Comparison of early characteristics of multisystemic inflammatory syndrome and Kawasaki disease in children and the course of Kawasaki disease in the pandemic;BMC Pediatrics;2024-07-30

3. Severity predictors for multisystemic inflammatory syndrome in children after SARS-CoV-2 infection in Vietnam;Scientific Reports;2024-07-09

4. Clinical presentation, diagnosis and management of multisystem inflammatory syndrome in children (MIS-C): a systematic review;BMJ Paediatrics Open;2024-06

5. Treatment of multisystem inflammatory syndrome in children;World Journal of Pediatrics;2024-03-21